We’re looking forward to an important conversation at MedTech MVP on June 1st:
Designing and Executing Device Trials That Secure Investment, Approval, and Adoption
Real-world lessons from MedTech CEOs who have navigated funding, FDA approval, and first-in-human trials.
Early clinical strategy decisions can shape far more than regulatory outcomes. They often influence investor confidence, funding timelines, and the long-term adoption of new technologies.
Join our panel as experienced MedTech leaders share practical lessons on navigating fundraising, FDA expectations, first-in-human trials, and the clinical decisions that can help de-risk development and accelerate growth.
We hope to see you there.
MedTech MedicalDevices ClinicalResearch StartupFunding FDA FirstInHuman #MedTechMVP ResearchDoneBright
